An observational study in Post-Dural Puncture Headache, sponsored by European Society of Anaesthesiology. Completed at 1 site in Sweden. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-02-15.
Sponsored by European Society of Anaesthesiology · Observational
The aims of EPiMAP Obstetrics are:
The primary aim of this prospective, international audit of practice is to identify risk factors for failure of epidural blood patch (EBP) in the Obstetric population after accidental dural puncture (ADP) with an epidural needle. Other aims are to describe the epidemiology, management principles, side effects and complications of ADP and longer-term effects of ADP on patients undergoing Obstetric anaesthesia and analgesia. Expectation is that this audit of practice will provide important information in understanding the reasons for failure of EBP and subsequently to better manage parturients affected by this debilitating complication.
Postdural puncture headache (PDPH) is the most common serious complication of accidental dural puncture (ADP), and feared by every Anaesthesiologist. It is associated with significant peri-partum maternal distress, and poor bonding with the baby, which in turn leads to physical disability for the mother and psychological and social implications for the whole family. It is estimated that about 10,000 parturients in Europe may have an accidental dural puncture (ADP) each year. Attitudes and practices in the management of ADP are based on small studies, and sometimes driven by experience rather than evidence. Although several methods have been described in the literature to treat PDPH, one common method used is an epidural blood patch (EBP). This is believed to be successful in about 60-80% of parturients on the first attempt, but results from most studies are based on a small numbers of patients. The reasons and predisposing factors for success and failure of different management strategies, specifically EBP, therefore needs to be investigated and described. Large observational studies on post-dural puncture headache in the Obstetric population are singularly absent from the literature.
125 studies on the registry are indexed under Post-Dural Puncture Headache; 25 are open to participants now.
This study's enrollment of 1,110 is above the median of 188 across 34 observational studies indexed under Post-Dural Puncture Headache.
Browse Post-Dural Puncture Headache studies →European Society of Anaesthesiology is the lead sponsor of 17 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All women ≥ 18 years old, who develop classical symptoms of post-dural puncture headache after epidural anaesthesia for labour or for caesarean section.
Exclusion Criteria:
To examine the risk factors for failed epidural blood patch (EBP) following post-dural puncture headache
To examine the risk factors for failed epidural blood patch (EBP) following post-dural puncture headache, in the obstetric population. Failure would be defined as lack of reduction in pain intensity by at least 50% at 24 h after application of EBP, compared to worst pain before EBP or a visual analogue pain score (VAS pain) of \> 3 at 24 h.
Time frame: 24 h after application of Epidural blood patch
European practices in the management of Post Dural Puncture Headache (PDPH)
Time frame: 24 h after application of Epidural blood patch
Incidence of significant Post Dural Puncture Headache (PDPH) and treatment failure in different countries in Europe
Time frame: 24 h after application of Epidural blood patch
Timing of the procedure (after diagnosis of PDPH) and the volume of blood injected in relation to success or failure
Time frame: 24 h after application of Epidural blood patch
Complications and side effects of Epidural blood patch (EBP)
Complications include : Chronic headache and backache, neurological injuries, audiological or visual other chronic impairments
Time frame: 24 h after application of Epidural blood patch
Variation in practices for management of Accidental Dural Puncture (ADP) in different European countries
Time frame: 24 h after application of Epidural blood patch
This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
European Society of Anaesthesiology